Patient Group Direction
Patient Group Direction
The updated PCS service (Pharmacy Contraceptive Service) specification and Patient Group Directions (PGDs) have now been published, ahead of planned service changes later this year. These updates include the addition of Drospirenone to the relevant PGD.
Exeltis is offering additional educational support on contraception and Slynd to help you feel confident in providing this medication to your patients.
Reporting Side Effects
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store. Adverse events should also be reported to Exeltis UK Limited by email to pharmacovigilance.uk@exeltis.com
E-learning module
Access this curated selection of training resources, conducted in association with the National Pharmacy Association (NPA), to build your competence and enhance your pharmacy team’s understanding of contraceptive choices.
Module 1: The Menstrual Cycle
Module 2 : General Contraception
Module 3 Slynd®: A Contraceptive Option
Webinars
Unlock critical knowledge for your pharmacy practice. Dive into key contraception topics with our expert-led, on-demand webinars, delivered in association with the National Pharmacy Association (NPA).
Login to Watch
Dr Jenine Bignall
Consultant in Sexual and Reproductive Health
How to Initiate Sexual Health Consultations
Login to Watch
Bushra Effendi
Pharmacist WSI Women’s Health
Initiating Oral
Contraception
Login to Watch
Bushra Effendi
Pharmacist WSI Women’s Health
An Update on the POP
PGD for Community
Pharmacists
